Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)
Running, not enrolling · Not applicable
Conditions studied: Type 1 Diabetes
In brief
To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.
Key facts
- Study ID
- NCT03968055
- Run by
- Stanford University
- People needed
- 100
- Starts
- 2019-03-25
- Expected to finish
- 2028-12-30
- Last updated by the study team
- 2026-05-08
Who can join
Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
- Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
- Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring
- Age: birth to < 21 years of age
You may not qualify if…
- Diabetes diagnosis other than T1D
- Diagnosis of diabetes > 1 month prior to initial visit
- Individuals with the intention of obtaining diabetes care at another clinic
- Individuals who do not consent to CGM use, CGM data integration, or remote monitoring
- Individuals > 21 years of age
Where it is running
- Lucile Packard Children's Hospital — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.